The life sciences investor is increasing ticket sizes and doubling down on speciality care and healthcare services as India ...
Last week's biggest large-cap decliners, led by Novo Nordisk, First Solar and Zoom, fell on earnings misses, weak guidance and drug-pricing worries.
Novo Nordisk A/S (NYSE:NVO) is one of the best cheap stocks under $50 to buy right now. Novo Nordisk A/S (NYSE:NVO) announced ...
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...
Novo Nordisk A/S (NYSE:NVO) is a global healthcare company specializing in diabetes care. It develops, discovers, ...
In a move expected to benefit thousands of New Jersey residents living with obesity and type 2 diabetes, Novo Nordisk, whose U.S. headquarters is based in Plainsboro, announced it will significantly ...
The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for ...
Novo Nordisk received approval from the Food and Drug Administration for three new indications of Sogroya, a growth hormone.
Novo Nordisk’s post-trial sell-off may be overdone. Click here for this comparative analysis of NVO and LLY stocks and see their valuation vs. realistic growth.
On Feb. 5, the Trump administration launched TrumpRx, a new digital platform designed to help Americans navigate the often-crushing costs of prescription drugs. While President Trump has called the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results